Frontage Laboratories
Frontage Laboratories is a global public CRDMO providing integrated drug discovery, development, bioanalytical, clinical, and CMC manufacturing services to pharmaceutical and biotechnology clients across 28 sites and approximately 2,200 employees in North America, Europe, and Asia-Pacific.
- Company typePublic
- Founded2001
- HeadquartersExton, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What Frontage Laboratories does
Frontage Laboratories is a global Contract Research, Development, and Manufacturing Organization (CRDMO) founded in 2001 and headquartered in Exton, Pennsylvania, with approximately 2,200 employees across 28 sites in North America, Asia-Pacific, and Europe. The company is publicly traded (Frontage Holdings Corporation, ticker hkg:1521) and operates under a horizontal B2B services model, serving pharmaceutical and biotechnology clients across the full drug development lifecycle. Service offerings span Drug Discovery Services (GDDS), Drug Development including DMPK and Safety/Toxicology, Clinical Services, Laboratory Testing Services (bioanalytical, central lab, genomics, biomarkers), and CMC product development and manufacturing. The portfolio has been expanded through acquisitions of Nucro-Technics (Canada, 2023), Accelera S.r.l. bioanalytical and DMPK businesses (Europe, 2024), and Teddy Clinical Research Laboratory (China, 2026), positioning Frontage as an integrated one-stop shop.
The company generates revenue through project-based, multi-year B2B contracts negotiated on scope, complexity, and timeline with pharmaceutical, biotechnology, generic drug, and agrochemical clients. Its technology stack includes proprietary assets such as the FRONTAGEMATRIX Logistic System for clinical trial sample tracking and kitting, and integrated LabVantage LIMS with EDC interoperability, alongside advanced analytical platforms including Quanterix Simoa HD-X for femtogram-level biomarker detection and Gyrolab for high-throughput immunoassays. The 2025 opening of a GMP manufacturing facility in Exton, Pennsylvania (validation completed October 2025) and the January 2026 launch of a 160-bed Phase I clinical unit in Secaucus, New Jersey have extended the platform from research services into clinical manufacturing and early-phase execution. Go-to-market is enterprise field sales with active participation in industry conferences (AAPS, WRIB, AACR, ACS, STP, ACT) and a content-driven marketing approach via the corporate website, resource library, LinkedIn, and YouTube channels. The company holds CAP accreditation, NGSP Level 1 certification, and IEC 27001:2022 certification, with 200+ successful FDA inspections cited as a regulatory track record.
Frontage Laboratories firmographics
Firmographics- Name
- Frontage Laboratories
- Legal name
- Frontage Laboratories, Inc.
- Website
- https://frontagelab.com
- Company type
- Public
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Frontage Laboratories is a global public CRDMO providing integrated drug discovery, development, bioanalytical, clinical, and CMC manufacturing services to pharmaceutical and biotechnology clients across 28 sites and approximately 2,200 employees in North America, Europe, and Asia-Pacific.
- Ownership category
- akta.pro rank
Frontage Laboratories industry classification
Industry- Product category
- Contract Research and Development Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
- akta.pro secondary industries
- Clinical CROs (Phase I–IV) (HLAGAAAA), Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB), Clinical Research & Trial Central Laboratories (HLAFAMAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL)
Keywords
Where Frontage Laboratories is headquartered
LocationHeadquarters
- HQ city
- Exton
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Frontage Laboratories business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Contract Research Services: B2B contract research organization (CRO) providing fee-for-service research across drug discovery, drug development, bioanalytical services, central lab services, and DMPK. Revenue generated through project-based contracts with pharmaceutical and biotech companies.
- Contract Development and Manufacturing (CDMO): CMC product development and manufacturing services including drug substance development, formulation development, clinical trial material (CTM) manufacturing, and commercial manufacturing. Revenue from GMP manufacturing contracts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based contract pricing for pharmaceutical/biotech clients |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
Frontage Laboratories product offering
Product offeringCore offering
Frontage Laboratories is a global Contract Research, Development and Manufacturing Organization (CRDMO) providing integrated, science-driven drug development services across the full lifecycle. Its offerings span drug discovery (chemistry, biology, ADME/Tox screening, pharmacology), drug development (DMPK, safety assessment/toxicology, early-phase clinical services), laboratory testing (bioanalytical for small and large molecules, central lab, genomics, biomarkers and precision medicine), and CMC product development and GMP manufacturing for drug substance, formulation, clinical trial materials, and commercial supply.
Product overview
Frontage Laboratories is a global Contract Research Organization (CRO) operating as a fully integrated CRDMO (Contract Research, Development and Manufacturing Organization) with 28 sites across North America, Asia-Pacific, and Europe and approximately 2,200 employees. The company offers an integrated 'one-stop shop' model spanning Drug Discovery Services (GDDS), Drug Development (DMPK, Safety & Toxicology, Clinical Services), Laboratory Testing Services (Bioanalytical, Central Lab, Genomics, Biomarkers & Precision Medicine), and CMC – Product Development & Manufacturing. The portfolio includes its own internal platforms (LabVantage LIMS, FRONTAGEMATRIX Logistic System) and has been expanded through acquisitions including Nucro-Technics (Canada, analytical chemistry/microbiology/toxicology), Accelera S.r.l. (bioanalytical and DMPK), and Teddy Clinical Research Laboratory (China, central lab services). A key infrastructure asset is the GMP manufacturing facility in Exton, PA opened in 2025. The company also offers dedicated Agrochemical Services in GLP-compliant facilities.
Differentiator
Problem solved
Functional benefit
Brands
- FRONTAGEMATRIX LOGISTIC SYSTEM™: Clinical trial logistics services system including kitting, supply chain management, digital sample tracking, and global distribution capabilities.
Products and services
- Drug Discovery Services (GDDS) End-to-end drug discovery services covering custom synthesis, medicinal chemistry, process chemistry and manufacturing, discovery biology, ADME/Tox screening, and pharmacology; helps pharmaceutical and biotech sponsors generate hits and leads and advance compounds to IND candidacy.
- Drug Metabolism & Pharmacokinetics (DMPK) Comprehensive DMPK services including in vitro assays (drug-drug interaction, enzyme kinetics, metabolite profiling, permeability and transporters, protein binding) and in vivo studies (pharmacokinetics, MIST, radiolabeled studies, QWBA, human C14 AME studies) for pharmaceutical and biotech sponsors.
- Safety Assessment & Toxicology Preclinical safety and toxicology services including safety pharmacology, genetic toxicology, general toxicology, developmental and reproductive toxicology (DART), global pathology services, toxicokinetics, and Standard for Exchange of Nonclinical Data (SEND) data services for pharmaceutical and biotech sponsors.
- Clinical Services Early phase clinical research capabilities including a 160-bed Phase I clinical unit in Secaucus, New Jersey, C14-hAME studies with onsite nuclear pharmacy, oncology Phase I trials, biometrics (biostatistics, data management, medical writing, statistical programming), and bioequivalence programs for pharmaceutical, biotech, and generic drug sponsors.
- Bioanalytical Services - Small & Large Molecules Bioanalytical testing for small molecules (mass spectrometry) and large molecules (biologics and bioassays) including method development and validation, ADC, cell and gene therapy, flow cytometry, LBA, automation, PK/TK studies, immunogenicity, sample management, and FTE services for pharmaceutical and biotech sponsors.
- Central Lab Services Comprehensive central laboratory services including histology and pathology, safety testing, specialty lab testing, biorepository services, clinical sample processing, clinical trial logistics via the FRONTAGEMATRIX Logistic System, biospecimen data services, and central lab e-portal for global clinical trial sponsors.
- Genomics Services Genomics testing including oncology services (ctDNA analysis, NGS oncology panel), pharmacogenetics, metagenomics and microbiome analysis, and genomic services for clinical biomarker profiling for pharmaceutical and biotech sponsors.
- Biomarkers & Precision Medicine Biomarker assay development and validation using Quanterix Simoa HD-X (femtogram/mL detection), ELISA, ECL-based assays, Gyrolab high-throughput immunoassays, and multiplexed NULISAseq panels for clinical biomarker profiling across disease areas including Alzheimer's disease, oncology, and neuroscience for biopharma sponsors.
- CMC - Product Development & Manufacturing Full-spectrum CDMO services covering drug substance development and manufacturing, product development (formulation, CTM manufacturing, commercial manufacturing), analytical services (small molecule and microbiological), and biologics, cell and gene therapy services, GMP routine testing, and stability programs for pharmaceutical and biotech sponsors.
- Agrochemical Services Support for agrochemical industry clients including biological, chemical, and regulatory support in GLP-compliant facilities for crop protection product development.
Quantifiable outcome
- Supported over 1,500 clinical trials contributing to regulatory approval of 50 new drugs
- +3 more outcomes
Companies that use Frontage Laboratories
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Frontage Laboratories technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature5 records
Frontage Laboratories partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- LabConnectcoreLabConnect opened a new central laboratory facility in Wuxi, China in collaboration with Teddy Laboratory (now part of Frontage Laboratories). The facility supports clinical trial services including custom kit building, sample tracking, logistics, and biorepository services. This expansion enables LabConnect to serve both multinational companies entering the China market and Chinese companies expanding internationally.
- GCCL (Global Central Lab)minorStrategic collaboration to strengthen global clinical trial capabilities, enhancing service offerings in clinical trial support and laboratory services across regions.
- EPNextS GroupminorCollaboration in early phase clinical trials, enabling expanded capabilities in Phase I clinical research services through partnership with regional hospitals and clinical networks.
- Medicover Integrated Clinical ServicescoreStrategic collaboration to expand global genomic testing services, combining Frontage's genomics capabilities with Medicover's clinical trial network to provide integrated solutions for pharmaceutical and biotech clients worldwide.
Scale indicators8 records
Recent moves11 records
Expansion highlights7 records
Frontage Laboratories competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Frontage Laboratories social profiles
Digital presenceFrontage Laboratories compliance and trust
Trust signalCompliance8 records
Frontage Laboratories financial estimates
Financial estimateRevenue estimate
Valuation estimate
Frontage Laboratories leadership team
Management profileNumber of profiles
Profiles9 records
Frontage Laboratories subsidiaries and ownership
Company hierarchySubsidiaries6 records
Frontage Laboratories funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Frontage Laboratories M&A and investment
M&A and investmentM&A7 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Frontage Laboratories
What does Frontage Laboratories do?
Frontage Laboratories is a global Contract Research, Development and Manufacturing Organization (CRDMO) providing integrated, science-driven drug development services across the full lifecycle. Its offerings span drug discovery (chemistry, biology, ADME/Tox screening, pharmacology), drug development (DMPK, safety assessment/toxicology, early-phase clinical services), laboratory testing (bioanalytical for small and large molecules, central lab, genomics, biomarkers and precision medicine), and CMC product development and GMP manufacturing for drug substance, formulation, clinical trial materials, and commercial supply.
Is Frontage Laboratories a public or private company?
Frontage Laboratories is a public company. It is classified as public and is currently operating.
When was Frontage Laboratories founded?
Frontage Laboratories was founded in 2001. It employs 501 to 1,000 people.
Where is Frontage Laboratories based?
Frontage Laboratories is headquartered in Exton, United States, in the North America region.
How does Frontage Laboratories make money?
Two revenue lines are on record. Contract Research Services are the primary driver. The others are contract Development and Manufacturing (CDMO).
Does Frontage Laboratories have an API?
No public API is recorded for Frontage Laboratories.
What industry is Frontage Laboratories in?
Frontage Laboratories's product category is Contract Research and Development Services. Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 541714 and its SIC code is 8731.